These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1133 related items for PubMed ID: 15496641

  • 1. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis.
    Yim DS, Zhou H, Buckwalter M, Nestorov I, Peck CC, Lee H.
    J Clin Pharmacol; 2005 Mar; 45(3):246-56. PubMed ID: 15703360
    [Abstract] [Full Text] [Related]

  • 3. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 5. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group.
    Arthritis Rheum; 2004 May 28; 50(5):1412-9. PubMed ID: 15146410
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.
    Zhou H, Jang H, Fleischmann RM, Bouman-Thio E, Xu Z, Marini JC, Pendley C, Jiao Q, Shankar G, Marciniak SJ, Cohen SB, Rahman MU, Baker D, Mascelli MA, Davis HM, Everitt DE.
    J Clin Pharmacol; 2007 Mar 28; 47(3):383-96. PubMed ID: 17322150
    [Abstract] [Full Text] [Related]

  • 8. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 28; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 9. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S.
    Ann Rheum Dis; 2006 Mar 28; 65(3):328-34. PubMed ID: 16079172
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul 28; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
    Yukawa E, Mori S, Ueda K, Nakada Y.
    J Clin Pharm Ther; 2007 Dec 28; 32(6):573-8. PubMed ID: 18021334
    [Abstract] [Full Text] [Related]

  • 12. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2006 Mar 28; 33(3):481-5. PubMed ID: 16463431
    [Abstract] [Full Text] [Related]

  • 13. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 28; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B, Etanercept Study Investigators.
    Ann Rheum Dis; 2009 Jul 28; 68(7):1113-8. PubMed ID: 18718986
    [Abstract] [Full Text] [Related]

  • 15. High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy.
    Min Y, Qiang F, Peng L, Zhu Z.
    Biopharm Drug Dispos; 2009 Nov 28; 30(8):437-47. PubMed ID: 19746402
    [Abstract] [Full Text] [Related]

  • 16. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
    Breedveld F, Agarwal S, Yin M, Ren S, Li NF, Shaw TM, Davies BE.
    J Clin Pharmacol; 2007 Sep 28; 47(9):1119-28. PubMed ID: 17766699
    [Abstract] [Full Text] [Related]

  • 17. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J, Carpentier N, Sabot C, Bertin P, Marquet P, Treves R, Merle L, Lachâtre G.
    Int J Clin Pharmacol Ther; 1998 Apr 28; 36(4):227-30. PubMed ID: 9587050
    [Abstract] [Full Text] [Related]

  • 18. Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis.
    Zhou H, Buckwalter M, Boni J, Mayer P, Raible D, Wajdula J, Fatenejad S, Sanda M.
    Int J Clin Pharmacol Ther; 2004 May 28; 42(5):267-76. PubMed ID: 15176649
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
    Kobelt G, Lindgren P, Singh A, Klareskog L.
    Ann Rheum Dis; 2005 Aug 28; 64(8):1174-9. PubMed ID: 15708879
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P.
    Cancer Chemother Pharmacol; 2006 Nov 28; 58(5):626-33. PubMed ID: 16528531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.